Market Place
Sourcing Support
Amylyx Rebuilds Momentum Following Relyvrio Market Withdrawal
24 Jul 2024 //
BIOSPACE
Amylyx Acquires Phase 3 GLP-1 Antagonist With FDA Breakthrough Status
10 Jul 2024 //
BUSINESSWIRE
Amylyx to buy bankrupt Eiger`s experimental drug to treat low blood sugar
22 Jun 2024 //
REUTERS
Sentynl Acquires Zokinvy® For Progeria From Eiger Globally
03 May 2024 //
PR NEWSWIRE
Eiger Files for Bankruptcy, Plans to Shutter Operations After Difficult Year
02 Apr 2024 //
BIOSPACE
Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection
01 Apr 2024 //
GLOBENEWSWIRE
Eiger files for bankruptcy and will wind down operations after years of setbacks
01 Apr 2024 //
ENDPTS
Eiger and Partner, AnGes, Receive Approval for Zokinvy) for Hutchinson
18 Jan 2024 //
PR NEWSWIRE
Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split
04 Jan 2024 //
PR NEWSWIRE
Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results
09 Nov 2023 //
PR NEWSWIRE
Eiger to discontinue late-stage hepatitis drug study over safety concerns
13 Sep 2023 //
REUTERS
Eiger to Present at H.C. Wainwright 25th Annual Global Investment Conference
05 Sep 2023 //
PR NEWSWIRE
Eiger BioPharmaceuticals Reports Second Quarter 2023 Financial Results
14 Aug 2023 //
PR NEWSWIRE
Eiger descends from COVID peak after pivoting, cuts 25% of staff
30 Jun 2023 //
FIERCE BIOTECH
Eiger BioPharmaceuticals to Focus on Metabolic Diseases with Avexitide
29 Jun 2023 //
PR NEWSWIRE
Eiger BioPharmaceuticals to Host Business Update Call Tomorrow
28 Jun 2023 //
PR NEWSWIRE
Eiger BioPharmaceuticals Reports 1Q 2023FYR &Provides Business Update
11 May 2023 //
PR NEWSWIRE
Eiger BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule
03 May 2023 //
BUSINESSWIRE
Eiger BioPharmaceuticals Appoints New Management Team
13 Apr 2023 //
CONTRACT PHARMA
Eiger BioPharmaceuticals Strengthens Management Team with New Appointments
13 Apr 2023 //
PR NEWSWIRE
Eiger Reports Fourth Quarter and Full Year 2022 Financial Results
16 Mar 2023 //
PR NEWSWIRE
Eiger BioPharmaceuticals Announces Leadership Change
15 Dec 2022 //
BUSINESSWIRE
Eiger Announces Both Lonafarnib-based Treatments in Pivotal PIII D-LIVR Trial
08 Dec 2022 //
PRNEWSWIRE
Eiger to Host Conference to Discuss Phase 3 D-LIVR Study Results of Lonafarnib
07 Dec 2022 //
PRNEWSWIRE
EIGR Investors Have Opportunity to Lead Eiger BioPharma Securities Fraud Lawsuit
02 Dec 2022 //
PRNEWSWIRE
Eiger BioPharmaceuticals Reports Third Quarter 2022 Financial Results
03 Nov 2022 //
PRNEWSWIRE
Eiger to Host Conference Call for Third Quarter 2022 Financial Results
24 Oct 2022 //
PRNEWSWIRE
Eiger to Present at the H.C. Wainwright Third Annual HBV Conference
11 Oct 2022 //
PRNEWSWIRE
FDA nixes EUA ambitions for Eiger’s COVID treatment
06 Oct 2022 //
FIERCEBIOTECH
Eiger to Present at the 2022 Ladenburg Thalmann Healthcare Conference
22 Sep 2022 //
PRNEWSWIRE
Eiger Provides Update on Status of Planned Peginterferon Lambda COVID-19 EUA
06 Sep 2022 //
PRNEWSWIRE
Eiger BioPharmaceuticals to Participate in Three Upcoming Investor Conferences
01 Sep 2022 //
PRNEWSWIRE
Eiger BioPharma Reports Second Quarter 2022 Financial Results
04 Aug 2022 //
PRNEWSWIRE
Eiger Bio to Host Conference Call for Q2 2022 Financial Results
28 Jul 2022 //
PRNEWSWIRE
Eiger Receives EU Approval for Zokinvy for Hutchinson-Gilford Progeria Syndrome
20 Jul 2022 //
PRNEWSWIRE
Eiger Appoints Lisa Kelly-Croswell to Board of Directors
18 Jul 2022 //
PRNEWSWIRE
Eiger Bio Announces Results from Multiple Presentations at EASL
27 Jun 2022 //
PRNEWSWIRE
Eiger BioPharma Announces New Data Supporting Broader Potential of Avexitide
13 Jun 2022 //
PRNEWSWIRE
Eiger BioPharmaceuticals Announces Multiple Presentations at the EASL
08 Jun 2022 //
PRNEWSWIRE
Eiger BioPharma Enters into $75M Term Loan and $5M Stock Purchase Agreement
07 Jun 2022 //
PRNEWSWIRE
Eiger BioPharma to Present at the Jefferies Global Healthcare Conference
03 Jun 2022 //
PRNEWSWIRE
Eiger Receives Positive CHMP Opinion for Zokinvy in HGPS and PDPL
20 May 2022 //
PRNEWSWIRE
Eiger BioPharma to Present at H.C. Wainwright Global Investment Conference
16 May 2022 //
PRNEWSWIRE
Eiger BioPharma, AnGes Announce Exclusive Partnership for Zokinvy in Japan
10 May 2022 //
PRNEWSWIRE
Eiger BioPharmaceuticals Reports First Quarter 2022 Financial Results
05 May 2022 //
PRNEWSWIRE
Eiger BioPharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
29 Apr 2022 //
PRNEWSWIRE
Eiger reports positive data from Phase II congenital hyperinsulinism trial
26 Apr 2022 //
CLINICALTRIALSARENA
Eiger Announces Publication of Positive Pha2 Results of Avexitide in Children
25 Apr 2022 //
PRNEWSWIRE
Eiger to Host Conference Call for First Quarter 2022 Financial Results
21 Apr 2022 //
PRNEWSWIRE
Eiger BioPharma Strengthens Leadership Team with New Executive Appointments
18 Apr 2022 //
PRNEWSWIRE
Eiger`s Peginterferon Lambda for COVID-19 Reduced Risk of Hospitalization
17 Mar 2022 //
PRNEWSWIRE
Eiger BioPharma to Discuss P 3 TOGETHER Study Results of Peginterferon Lambda
16 Mar 2022 //
PRNEWSWIRE
Eiger Bio to Host Conference Call to Discuss Phase 3 TOGETHER Study Results
16 Mar 2022 //
PRESS RELEASE
Eiger BioPharmaceuticals Reports Q4 and Full Year 2021 Financial Results
10 Mar 2022 //
PRNEWSWIRE
Eiger Bio to Host Conference Call for Q4 & Full Year 2021 Financial Results
24 Feb 2022 //
PRNEWSWIRE
Eiger BioPharma Announces Outlook and Planned 2022 Catalysts and Milestones
06 Jan 2022 //
PRNEWSWIRE
Eiger Begins Enrollment in LIMT-2 Phase 3 Study of Peginterferon Lambda
21 Dec 2021 //
PRNEWSWIRE
Eiger obtains DSMB advice to continue Phase III Covid-19 therapy trial
16 Dec 2021 //
CLINICALTRIALSARENA
Eiger Shows Second Interim Analysis, Ongoing Dosing in Phase 3 TOGETHER Study
15 Dec 2021 //
PRNEWSWIRE
Eiger BioPharmaceuticals Reports Third Quarter 2021 Financial Results
04 Nov 2021 //
PRNEWSWIRE
